254
Participants
Start Date
November 1, 2025
Primary Completion Date
November 1, 2027
Study Completion Date
November 1, 2028
Normobaric oxygen therapy
Patient's exposure to NBO conditions in group 1 (aNBO) including: oxygen levels of 32-40% (compared to about 21% in the atmosphere), pressure maintained at 1,500 hPa (about 1,000 hPa outside), carbon dioxide levels between 0.7-1.9% (compared to 0.03% in the atmosphere, and hydrogen levels between 0.5-1% (which is 10 to 20 thousand times higher than in the atmosphere). Exposure time in the NBO chamber will be the standard 2 hours with an additional 20 minutes for preparation and adaptation and 10 minutes for finalization and the decompression period.
Normobaric oxygen therapy
Patients' exposure to atmospheric conditions in the same NBO chamber (without normobaric conditions to provide placebo intervention as the study comparator) in group 2 (pNBO): oxygen levels about 21%, pressure maintained at about 1,000 hPa, carbon dioxide levels about o 0.03%, and hydrogen levels about 0.00005% (0.5 parts per million, like in the atmos-phere).
4th Military Clinical Hospital, Wroclaw
Wroclaw Medical University (Poland)
UNKNOWN
Wroclaw University of Science and Technology (Poland)
UNKNOWN
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (Poland)
UNKNOWN
WSB Merito University in Opole (Poland)
UNKNOWN
Academy of Applied Sciences in Nowy Sacz (Poland)
UNKNOWN
4th Military Clinical Hospital with Polyclinic, Poland
OTHER